Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Engineering Gut Microbiome to Target Breast Cancer

NCT03358511 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03358511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03358511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Engineering Gut Microbiome to Target Breast Cancer
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2017
Completion date
May 19, 2020
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer